Share Zenas BioPharma, Inc. (ZBIO) R&D Event: Obexelimab in SLE and ZB021 Development Transcript

Seeking Alpha · ZBIO · October 27, 2026

Zenas BioPharma, Inc. (ZBIO) R&D Event: Obexelimab in SLE and ZB021 Development Transcript

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: Seeking Alpha ↗